CareDx (CDNA) Common Equity (2013 - 2026)

CareDx (CDNA) has 14 years of Common Equity data on file, last reported at $313.5 million in Q1 2026.

• Quarterly Common Equity fell 17.35% year-over-year to $313.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $313.5 million (down 17.35% YoY) and the FY2025 annual result came in at $303.1 million, down 19.91% from the prior year.
• Common Equity climbed to $313.5 million in Q1 2026 per CDNA's latest filing, from $303.1 million in the prior quarter.
• The five-year high for Common Equity was $457.5 million in Q1 2022, with the low at $256.2 million in Q1 2024.
• Average Common Equity over 5 years is $356.3 million, with a median of $378.4 million recorded in 2024.
• Year-over-year, Common Equity slumped 39.35% in 2023 and soared 48.05% in 2025.
• CareDx's Common Equity stood at $430.9 million in 2022, then tumbled by 39.35% to $261.3 million in 2023, then soared by 44.81% to $378.4 million in 2024, then slipped by 19.91% to $303.1 million in 2025, then gained by 3.44% to $313.5 million in 2026.
• Business Quant data shows CDNA's Common Equity at $313.5 million in Q1 2026, $303.1 million in Q4 2025, and $311.1 million in Q3 2025.